Modulation of growth-related gene expression and growth inhibition by cyclic adenosine 3',5'-monophosphate-elevating

C Lavergne1, B Breant, G Rosselin

  • 1Unité INSERM 55, Hôpital Saint-Antoine, Paris, France.

Endocrinology
|November 1, 1992
PubMed

Insights

Elevating cyclic AMP (cAMP) levels with IBMX or forskolin inhibits beta TC1 cell proliferation and insulin release. These compounds modulate cell cycle gene expression, impacting growth and function.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Molecular Biology

Background:

  • The cAMP pathway plays a crucial role in cellular regulation.
  • Understanding beta-cell function is vital for diabetes research.
  • Regulation of beta-cell proliferation and function is complex.

Purpose of the Study:

  • To investigate the role of the cAMP pathway in regulating beta TC1 cell growth.
  • To examine how increased cAMP affects the cell cycle of quiescent beta TC1 cells.
  • To determine the impact of cAMP on insulin release and gene expression in beta TC1 cells.

Main Methods:

  • Utilized phosphodiesterase inhibitor IBMX and adenylate cyclase activator forskolin to modulate cAMP levels.
  • Measured intracellular cAMP concentrations and insulin release.
  • Analyzed the expression of cell cycle-related genes (c-fos, c-jun) and SV40 T-antigen mRNA.

Main Results:

  • Both IBMX and forskolin inhibited serum-induced proliferation in a dose-dependent manner.
  • cAMP levels increased significantly with IBMX and forskolin treatment.
  • These agents induced insulin release and modulated c-fos and c-jun gene expression.
  • IBMX and forskolin inhibited serum-induced SV40 T-antigen mRNA accumulation.

Conclusions:

  • Elevated cAMP levels inhibit beta TC1 cell proliferation and induce insulin release, characteristic of differentiated beta-cells.
  • The cAMP pathway influences cell cycle regulation through modulation of specific gene expression.
  • These findings provide insights into the control of beta-cell growth and function via cAMP signaling.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...